LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Jan 8, 2026, 4:00 PM EST
LadRx Market Cap
LadRx has a market cap or net worth of $5.45 thousand as of January 9, 2026. Its market cap has decreased by -99.45% in one year.
Market Cap
5.45K
Enterprise Value
-201.50K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 5.45K, a decrease of -99.99%. That is a compound annual growth rate of -22.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 5.45K | -99.35% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 527.53M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |